> USystemic immunosuppression The use of systemic CORTICOSTEROIDS and OTHER IMMUNOSUPPRESSANTS at baseline, before starting  NIVOLUMAB in combination wit h RELATLIMAB , should be avoided because of their potential interference with the pharmacodynamic  activity. However, systemic CORTICOSTEROIDS and OTHER IMMUNOSUPPRESSANTS can be used after starting  NIVOLUMAB in combination with RELATLIMAB  to treat immune -related adverse reactions. 
